CD62Llow effector T-cell subsets were stimulated in vitro for 1–2 weeks with DCs pulsed with the immunizing peptides or, for the group immunized with rotating tumor cell lysates, with B16.MUC1 tumor lysate not used during previous in vivo priming. Here, MUC1 is linked to neoplasm.